231 related articles for article (PubMed ID: 20686370)
1. Alternative splicing-related factor YT521: an independent prognostic factor in endometrial cancer.
Zhang B; zur Hausen A; Orlowska-Volk M; Jäger M; Bettendorf H; Stamm S; Hirschfeld M; Yiqin O; Tong X; Gitsch G; Stickeler E
Int J Gynecol Cancer; 2010 May; 20(4):492-9. PubMed ID: 20686370
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-dependent mRNA expression pattern of splicing factor YT521 and its impact on oncological important target gene expression.
Hirschfeld M; Zhang B; Jaeger M; Stamm S; Erbes T; Mayer S; Tong X; Stickeler E
Mol Carcinog; 2014 Nov; 53(11):883-92. PubMed ID: 23765422
[TBL] [Abstract][Full Text] [Related]
3. Alterations in expression pattern of splicing factors in epithelial ovarian cancer and its clinical impact.
Iborra S; Hirschfeld M; Jaeger M; Zur Hausen A; Braicu I; Sehouli J; Gitsch G; Stickeler E
Int J Gynecol Cancer; 2013 Jul; 23(6):990-6. PubMed ID: 23748175
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of Musashi-1 in endometrioid adenocarcinoma.
Ma L; Xu YL; Ding WJ; Shao HF; Teng YC
Int J Clin Exp Pathol; 2015; 8(5):4564-72. PubMed ID: 26191146
[TBL] [Abstract][Full Text] [Related]
5. The evaluation of the FOXO1, KLF9 and YT521 genes expression in human endometrial cancer.
Korani M; Fallah S; Tehranian A; Nourbakhsh M; Samadikuchaksaraei A; Pour MS; Maleki J
Clin Lab; 2013; 59(5-6):483-9. PubMed ID: 23865345
[TBL] [Abstract][Full Text] [Related]
6. HNRNP G and HTRA2-BETA1 regulate estrogen receptor alpha expression with potential impact on endometrial cancer.
Hirschfeld M; Ouyang YQ; Jaeger M; Erbes T; Orlowska-Volk M; Zur Hausen A; Stickeler E
BMC Cancer; 2015 Feb; 15():86. PubMed ID: 25884434
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of Sam68 expression in endometrial carcinoma.
Wang Q; Li Y; Zhou J; Liu J; Qin J; Xing F; Zhang J; Cheng J
Tumour Biol; 2015 Jun; 36(6):4509-18. PubMed ID: 25874492
[TBL] [Abstract][Full Text] [Related]
8. Expression levels of hnRNP G and hTra2-beta1 correlate with opposite outcomes in endometrial cancer biology.
Ouyang YQ; zur Hausen A; Orlowska-Volk M; Jäger M; Bettendorf H; Hirschfeld M; Tong XW; Stickeler E
Int J Cancer; 2011 May; 128(9):2010-9. PubMed ID: 20607830
[TBL] [Abstract][Full Text] [Related]
9. CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.
Chen S; Yang C; Wang ZW; Hu JF; Pan JJ; Liao CY; Zhang JQ; Chen JZ; Huang Y; Huang L; Zhan Q; Tian YF; Shen BY; Wang YD
J Hematol Oncol; 2021 Apr; 14(1):60. PubMed ID: 33849617
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer.
Fu DY; Tan HS; Wei JL; Zhu CR; Jiang JX; Zhu YX; Cai FL; Chong MH; Ren CL
Tumour Biol; 2015 Sep; 36(10):8025-34. PubMed ID: 25971583
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of NF-YA splicing isoforms and Lamin A status in low grade endometrial cancer.
Cicchillitti L; Corrado G; Carosi M; Dabrowska ME; Loria R; Falcioni R; Cutillo G; Piaggio G; Vizza E
Oncotarget; 2017 Jan; 8(5):7935-7945. PubMed ID: 27974701
[TBL] [Abstract][Full Text] [Related]
12. YT521 promotes metastases of endometrial cancer by differential splicing of vascular endothelial growth factor A.
Zhang B; Shao X; Zhou J; Qiu J; Wu Y; Cheng J
Tumour Biol; 2015 Aug; ():. PubMed ID: 26289848
[TBL] [Abstract][Full Text] [Related]
13. Receptor Activator of Nuclear Factor Kappa B (RANK) and Clinicopathological Variables in Endometrial Cancer: A Study at Protein and Gene Level.
Gómez R; Castro A; Martínez J; Rodríguez-García V; Burgués O; Tarín JJ; Cano A
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29932437
[TBL] [Abstract][Full Text] [Related]
14. WNT5A gene and protein expression in endometrial cancer.
Wasniewski T; Kiezun J; Krazinski BE; Kowalczyk AE; Szostak B; Wierzbicki PM; Kiewisz J
Folia Histochem Cytobiol; 2019; 57(2):84-93. PubMed ID: 31198984
[TBL] [Abstract][Full Text] [Related]
15. Rictor is an independent prognostic factor for endometrial carcinoma.
Wen SY; Li CH; Zhang YL; Bian YH; Ma L; Ge QL; Teng YC; Zhang ZG
Int J Clin Exp Pathol; 2014; 7(5):2068-78. PubMed ID: 24966915
[TBL] [Abstract][Full Text] [Related]
16. Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer.
Li D; Peng X; Yan D; Tang H; Huang F; Yang Y; Peng Z
Ann Surg Oncol; 2011 Jul; 18(7):2074-83. PubMed ID: 21442350
[TBL] [Abstract][Full Text] [Related]
17. Reduced mRNA expression levels of NFE2L2 are associated with poor outcome in breast cancer patients.
Wolf B; Goebel G; Hackl H; Fiegl H
BMC Cancer; 2016 Oct; 16(1):821. PubMed ID: 27770790
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of SIP1 and downregulation of E-cadherin predict delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma after partial glossectomy.
Sakamoto K; Imanishi Y; Tomita T; Shimoda M; Kameyama K; Shibata K; Sakai N; Ozawa H; Shigetomi S; Fujii R; Fujii M; Ogawa K
Ann Surg Oncol; 2012 Feb; 19(2):612-9. PubMed ID: 21913013
[TBL] [Abstract][Full Text] [Related]
19. CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases.
Wuttig D; Zastrow S; Füssel S; Toma MI; Meinhardt M; Kalman K; Junker K; Sanjmyatav J; Boll K; Hackermüller J; Rolle A; Grimm MO; Wirth MP
Int J Cancer; 2012 Sep; 131(5):E693-704. PubMed ID: 22213152
[TBL] [Abstract][Full Text] [Related]
20. Identification of chimeric TSNAX-DISC1 resulting from intergenic splicing in endometrial carcinoma through high-throughput RNA sequencing.
Li N; Zheng J; Li H; Deng J; Hu M; Wu H; Li W; Li F; Lan X; Lu J; Zhou Y
Carcinogenesis; 2014 Dec; 35(12):2687-97. PubMed ID: 25239642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
